Vaxil was founded by Weizmann Institute scientists, Israel’s top research university, in order to provide an altogether novel approach to immunotherapy. Vaxil has diligently advanced its immunotherapy platform and published its research and clinical results in top medical journals.

About Vaxil Immunotherapy


Learn More

About Vaxil’s History


Learn More

Scientific Publications


Learn More

Intellectual Property


Learn More